Malaysia’s leading healthcare industry supply chain management provider, Hong Seng Group through its subsidiary, HS Bio Sdn Bhd, has agreed to collaborate with Mediven Innovation Ventures (Mediven) to jointly work on the supply of healthcare products and services.
The companies will evaluate potential markets and opportunities for their products and may jointly pursue tenders and bids for projects by offering a more comprehensive range of solutions. Hong Seng Executive Mediven Operations Director Dr. Lim Li Sze remarked that both parties intend to build up substantial contributions to enhance health and address infectious diseases.
HS Bio covers a wide range of healthcare solutions including digital health, laboratory testing, R&D, and medical supplies. The firm and its healthcare subsidiaries have also extended their healthcare business from providing 3rd party and 4th party logistics services to the entire end-to-end healthcare supply chain. Mediven is a molecular diagnostics designer and supplier of GenoAmpTM and ProDetectTM series of products, which are mainly used for infectious diseases.
(Sources: The Edge Markets; New Straits Times)
